Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance
Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
Potential of Ayurveda’s contribution in global health system through various innovative practices
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
Quinidine Sulphate helps manage rare irregular heartbeat conditions
Subscribe To Our Newsletter & Stay Updated
